You are here
Name change, new ambitions for Biogen
BIOGEN IDEC Inc has seen its market value quadruple in three years to more than US$100 billion on the back of its successful multiple sclerosis drugs. Now it has new ambitions in its sights.
The Massachusetts-based company, which made headlines last week when it announced
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org